Genizon Biosciences Announces a License and Collaboration Agreement with Pfizer in Three Major Diseases
Collaboration using "Quebec Founder Population" in genome-wide association studies to be used to develop diagnostics
18-Jan-2007 -
Genizon BioSciences announced a license and collaboration agreement with Pfizer Inc. for diagnostic rights to Genizon's discovery programs in Alzheimer's disease, attention deficit hyperactivity disorder and endometriosis. Genizon retains therapeutic rights.
Under the terms of the agreement, ...
Alzheimer's disease
diagnostics
diseases
+2